Insider Buying in Clovis Oncology, Inc. (CLVS)

On Aug 16, 2019, Patrick Mahaffy – President and CEO of Clovis Oncology, Inc. (CLVS) – purchased 50,000 shares of CLVS at $5.59. His out of pocket cost was $279,576.